Статті в журналах з теми "Vaccine schedule and formulation"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "Vaccine schedule and formulation".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Platt, Andrew, Munir Mosaheb, Adam Gower, and Lee Wetzler. "Transcriptome analysis of N. meningitidis PorB as an adjuvant in a multi-injection vaccination schedule (P4494)." Journal of Immunology 190, no. 1_Supplement (May 1, 2013): 178.1. http://dx.doi.org/10.4049/jimmunol.190.supp.178.1.
Повний текст джерелаTzeng, Stephany Y., Kevin J. McHugh, Adam M. Behrens, Sviatlana Rose, James L. Sugarman, Shiran Ferber, Robert Langer, and Ana Jaklenec. "Stabilized single-injection inactivated polio vaccine elicits a strong neutralizing immune response." Proceedings of the National Academy of Sciences 115, no. 23 (May 21, 2018): E5269—E5278. http://dx.doi.org/10.1073/pnas.1720970115.
Повний текст джерелаPettini, Elena, Gabiria Pastore, Fabio Fiorino, Donata Medaglini, and Annalisa Ciabattini. "Short or Long Interval between Priming and Boosting: Does It Impact on the Vaccine Immunogenicity?" Vaccines 9, no. 3 (March 20, 2021): 289. http://dx.doi.org/10.3390/vaccines9030289.
Повний текст джерелаTrevisan, Andrea, Paola Mason, Annamaria Nicolli, Stefano Maso, Bruno Scarpa, Angelo Moretto, and Maria Luisa Scapellato. "Vaccination and Immunity toward Measles: A Serosurvey in Future Healthcare Workers." Vaccines 9, no. 4 (April 13, 2021): 377. http://dx.doi.org/10.3390/vaccines9040377.
Повний текст джерелаAguilar, Julio Cesar, Jorge Agustin Aguiar, and Sheikh Mohammad Fazle Akbar. "Action Mechanisms and Scientific Rationale of Using Nasal Vaccine (HeberNasvac) for the Treatment of Chronic Hepatitis B." Vaccines 10, no. 12 (December 7, 2022): 2087. http://dx.doi.org/10.3390/vaccines10122087.
Повний текст джерелаCajaraville, Ana Carolina dos Reis Albuquerque, Mariana Pierre de Barros Gomes, Tamiris Azamor, Renata Carvalho Pereira, Patrícia Cristina da Costa Neves, Paula Mello De Luca, Sheila Maria Barbosa de Lima, et al. "Evaluation of Two Adjuvant Formulations for an Inactivated Yellow Fever 17DD Vaccine Candidate in Mice." Vaccines 11, no. 1 (December 28, 2022): 73. http://dx.doi.org/10.3390/vaccines11010073.
Повний текст джерелаMeneveau, Max O., Pankaj Kumar, Kevin T. Lynch, Sapna P. Patel, and Craig L. Slingluff. "The vaccine-site microenvironment: impacts of antigen, adjuvant, and same-site vaccination on antigen presentation and immune signaling." Journal for ImmunoTherapy of Cancer 10, no. 3 (March 2022): e003533. http://dx.doi.org/10.1136/jitc-2021-003533.
Повний текст джерелаNiemuth, Nancy A., Carol L. Sabourin, and Lucy A. Ward. "Adapting Simon’s Two-Stage Design for Efficient Screening of Filovirus Vaccines in Non-Human Primates." Vaccines 10, no. 8 (July 29, 2022): 1216. http://dx.doi.org/10.3390/vaccines10081216.
Повний текст джерелаBekele, Yonas, Jay A. Berzofsky, and Francesca Chiodi. "Undetectable Anti-HBs Antibodies: Need of a Booster Dose for HIV-1-Infected Individuals." Vaccines 9, no. 12 (December 15, 2021): 1484. http://dx.doi.org/10.3390/vaccines9121484.
Повний текст джерелаMabel Cruz, Rodríguez, Báez Gretchen Bergado, Luna Yerandy Hechevarría, Fernández Diana Rosa Hernández, Palomo Addys González, Suárez Narjara González, Castillo Carlos Yordan González, Lorenzo María del Carmen Luzardo, García Lisset Chao, and Ramírez Belinda Sánchez. "The combination of very-small size proteoliposomes and alum is a safe adjuvant alternative for inducing anti-EGF antibodies: a preclinical study." Archives of Cancer Science and Therapy 6, no. 1 (September 20, 2022): 018–30. http://dx.doi.org/10.29328/journal.acst.1001029.
Повний текст джерелаJohnston, Sara C., Keersten M. Ricks, Ines Lakhal-Naouar, Alexandra Jay, Caroline Subra, Jo Lynne Raymond, Hannah A. D. King, et al. "A SARS-CoV-2 Spike Ferritin Nanoparticle Vaccine Is Protective and Promotes a Strong Immunological Response in the Cynomolgus Macaque Coronavirus Disease 2019 (COVID-19) Model." Vaccines 10, no. 5 (May 4, 2022): 717. http://dx.doi.org/10.3390/vaccines10050717.
Повний текст джерелаLawrence, Jody, Nicholas Kitchin, Annaliesa S. Anderson, Michael W. Pride, Kathrin U. Jansen, William C. Gruber, Yahong Peng, Kevin Yi, Charles Knirsch, and Chris Webber. "12. Randomized Studies of Two Clostridioides (Clostridium) difficile Vaccine Formulations." Open Forum Infectious Diseases 7, Supplement_1 (October 1, 2020): S29. http://dx.doi.org/10.1093/ofid/ofaa439.057.
Повний текст джерелаHonda-Okubo, Yoshikazu, Jeremy Baldwin, and Nikolai Petrovsky. "Advax-CpG Adjuvant Provides Antigen Dose-Sparing and Enhanced Immunogenicity for Inactivated Poliomyelitis Virus Vaccines." Pathogens 10, no. 5 (April 21, 2021): 500. http://dx.doi.org/10.3390/pathogens10050500.
Повний текст джерелаLopez, Pio, Yolanda Caicedo, Alexandra Sierra, Sandrine Tilman, Ralf Clemens, and Angelika Banzhoff. "Combined Administration of MF59-Adjuvanted A/H5N1 Prepandemic and Seasonal Influenza Vaccines: Long-Term Antibody Persistence and Robust Booster Responses 1 Year after a One-Dose Priming Schedule." Clinical and Vaccine Immunology 20, no. 5 (March 27, 2013): 753–58. http://dx.doi.org/10.1128/cvi.00626-12.
Повний текст джерелаMoon, James E., Christian Ockenhouse, Jason A. Regules, Johan Vekemans, Cynthia Lee, Ilin Chuang, Magali Traskine, et al. "A Phase IIa Controlled Human Malaria Infection and Immunogenicity Study of RTS,S/AS01E and RTS,S/AS01B Delayed Fractional Dose Regimens in Malaria-Naive Adults." Journal of Infectious Diseases 222, no. 10 (July 20, 2020): 1681–91. http://dx.doi.org/10.1093/infdis/jiaa421.
Повний текст джерелаEllis, John, Elizabeth Marziani, Chumkee Aziz, Catherine M. Brown, Leah A. Cohn, Christopher Lea, George E. Moore, and Neha Taneja. "2022 AAHA Canine Vaccination Guidelines." Journal of the American Animal Hospital Association 58, no. 5 (September 1, 2022): 213–30. http://dx.doi.org/10.5326/jaaha-ms-canine-vaccination-guidelines.
Повний текст джерелаPark, Min-Hye, Ji Won You, Hyoung Jin Kim, and Hong-Jin Kim. "IgG and IgM responses to human papillomavirus L1 virus-like particle as a function of dosing schedule and vaccine formulation." Journal of Microbiology 57, no. 9 (August 27, 2019): 821–27. http://dx.doi.org/10.1007/s12275-019-9308-z.
Повний текст джерелаBendandi, Maurizio, Carlos Becerra, Joseph Kuhn, Suncica Hukic, Nyla Langford, Taizoon Khokhar, Victor Klimyuk, et al. "Idiotypic Vaccination of Patients with Relapsed Follicular Lymphoma Using a Novel Vaccine Formulation Including a Tobacco Plant-Produced Tumor Specific Idiotype." Blood 118, no. 21 (November 18, 2011): 1649. http://dx.doi.org/10.1182/blood.v118.21.1649.1649.
Повний текст джерелаTricou, Vianney, Shibadas Biswal, Mengya Liu, Sanjay S. Patel, Olaf Zent, Martina Rauscher, Gonzalo Perez, Walid Kandeil, and Nicolas Folschweiller. "97. Tetravalent Dengue Vaccine (TAK-003) Development Program: A Bird’s Eye View." Open Forum Infectious Diseases 8, Supplement_1 (November 1, 2021): S61. http://dx.doi.org/10.1093/ofid/ofab466.097.
Повний текст джерелаFlick-Smith, Helen C., Jim E. Eyles, Richard Hebdon, Emma L. Waters, Richard J. Beedham, Tony J. Stagg, Julie Miller, H. Oya Alpar, Les W. J. Baillie, and E. Diane Williamson. "Mucosal or Parenteral Administration of Microsphere-Associated Bacillus anthracis Protective Antigen Protects against Anthrax Infection in Mice." Infection and Immunity 70, no. 4 (April 2002): 2022–28. http://dx.doi.org/10.1128/iai.70.4.2022-2028.2002.
Повний текст джерелаde Bruyn, Guy, Jamshid Saleh, David Workman, Richard Pollak, Victor Elinoff, Neil J. Fraser, Gigi Lefebvre, et al. "Defining the optimal formulation and schedule of a candidate toxoid vaccine against Clostridium difficile infection: A randomized Phase 2 clinical trial." Vaccine 34, no. 19 (April 2016): 2170–78. http://dx.doi.org/10.1016/j.vaccine.2016.03.028.
Повний текст джерелаBonvehí, Pablo, Dominique Boutriau, Javier Casellas, Vincent Weynants, Christiane Feron, and Jan Poolman. "Three Doses of an Experimental Detoxified L3-Derived Lipooligosaccharide Meningococcal Vaccine Offer Good Safety but Low Immunogenicity in Healthy Young Adults." Clinical and Vaccine Immunology 17, no. 9 (July 21, 2010): 1460–66. http://dx.doi.org/10.1128/cvi.00129-10.
Повний текст джерелаArmbruster, Jasny, and Petsch. "Advances in RNA Vaccines for Preventive Indications: A Case Study of A Vaccine Against Rabies." Vaccines 7, no. 4 (September 27, 2019): 132. http://dx.doi.org/10.3390/vaccines7040132.
Повний текст джерелаButler, Anne M., Jason Newland, John Sahrmann, Caroline O’Neil, Sena Sayood, and Leah McGrath. "1383. Characterizing Real-world Patterns of Early Childhood Vaccination." Open Forum Infectious Diseases 7, Supplement_1 (October 1, 2020): S701. http://dx.doi.org/10.1093/ofid/ofaa439.1565.
Повний текст джерелаWieczorek, Lindsay, Shelly J. Krebs, Vaniambadi Kalyanaraman, Stephen Whitney, Sodsai Tovanabutra, Carlos G. Moscoso, Eric Sanders-Buell, et al. "Comparable Antigenicity and Immunogenicity of Oligomeric Forms of a Novel, Acute HIV-1 Subtype C gp145 Envelope for Use in Preclinical and Clinical Vaccine Research." Journal of Virology 89, no. 15 (May 13, 2015): 7478–93. http://dx.doi.org/10.1128/jvi.00412-15.
Повний текст джерелаNisar, Muhammad Imran, Fyezah Jehan, Shahira Shahid, Sheraz Ahmed, Sadia Shakoor, Furqan Kabir, Aneeta Hotwani, et al. "Serotype-specific effectiveness against pneumococcal carriage and serotype replacement after ten-valent Pneumococcal Conjugate Vaccine (PCV10) introduction in Pakistan." PLOS ONE 17, no. 1 (January 21, 2022): e0262466. http://dx.doi.org/10.1371/journal.pone.0262466.
Повний текст джерелаKouenkam, Jean Pierre II, Joseph Mbang, and Yves Emvudu. "Global dynamics of a model of hepatitis B virus infection in a sub-Saharan African rural area." International Journal of Biomathematics 13, no. 06 (July 23, 2020): 2050054. http://dx.doi.org/10.1142/s1793524520500540.
Повний текст джерелаHuang, Haibin, Gary R. Ostroff, Chrono K. Lee, Charles A. Specht, and Stuart M. Levitz. "Characterization and Optimization of the Glucan Particle-Based Vaccine Platform." Clinical and Vaccine Immunology 20, no. 10 (August 14, 2013): 1585–91. http://dx.doi.org/10.1128/cvi.00463-13.
Повний текст джерелаBabicki, Mateusz. "Will Bivalent Vaccination against COVID-19 Increase the Desire for COVID-19 Vaccination among Poles?" Vaccines 10, no. 10 (October 3, 2022): 1658. http://dx.doi.org/10.3390/vaccines10101658.
Повний текст джерелаSoulieres, D., C. Smith, P. M. Ellis, N. Murray, K. Jasas, A. Maksymiuk, G. Goss, M. H. Falk, and C. Butts. "A multi-centre, open-label study to assess the safety of Stimuvax (BLP25 liposome vaccine or L-BLP25) in non-small cell lung cancer (NSCLC) patients (pts) with unresectable stage III disease." Journal of Clinical Oncology 25, no. 18_suppl (June 20, 2007): 3075. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.3075.
Повний текст джерелаTica, Jelena, Javier Ruiz Guiñazú, Charles P. Andrews, Matthew G. Davis, Brandon Essink, Charles Fogarty, Edward Kerwin, et al. "119. A Respiratory Syncytial Virus Prefusion F Protein (RSVPreF3) Candidate Vaccine Administered in Older Adults in a Phase I/II Randomized Clinical Trial Is Well Tolerated." Open Forum Infectious Diseases 7, Supplement_1 (October 1, 2020): S187—S188. http://dx.doi.org/10.1093/ofid/ofaa439.429.
Повний текст джерелаZanella, Beatrice, Angela Bechini, Benedetta Bonito, Marco Del Riccio, Alessandra Ninci, Emilia Tiscione, Paolo Bonanni, and Sara Boccalini. "A Study of Varicella Seroprevalence in a Pediatric and Adolescent Population in Florence (Italy). Natural Infection and Vaccination-Acquired Immunization." Vaccines 9, no. 2 (February 14, 2021): 152. http://dx.doi.org/10.3390/vaccines9020152.
Повний текст джерелаGuiñazú, Javier Ruiz, Jelena Tica, Charles P. Andrews, Matthew G. Davis, Philippe De Smedt, Brandon Essink, Charles Fogarty, et al. "121. A Respiratory Syncytial Virus Prefusion F Protein (RSVPreF3) Candidate Vaccine Administered in Older Adults in a Phase I/II Randomized Clinical Trial Is Immunogenic." Open Forum Infectious Diseases 7, Supplement_1 (October 1, 2020): S188—S189. http://dx.doi.org/10.1093/ofid/ofaa439.431.
Повний текст джерелаRidad, Geraldine Sabate. "BARRIERS TO ADHERENCE TO EXPANDED PROGRAM ON IMMUNIZATION AMONG PARENTS IN LANAO DEL NORTE, PHILIPPINES." Belitung Nursing Journal 5, no. 1 (February 13, 2019): 16–22. http://dx.doi.org/10.33546/bnj.695.
Повний текст джерелаConti, Andrea, Gaia Broglia, Chiara Sacchi, Fabrizia Risi, Francesco Barone-Adesi, and Massimiliano Panella. "Efficacy and Safety of Quadrivalent Conjugate Meningococcal Vaccines: A Systematic Review and Meta-Analysis." Vaccines 11, no. 1 (January 13, 2023): 178. http://dx.doi.org/10.3390/vaccines11010178.
Повний текст джерелаNavarrete, Marcelo A., Kristina Heining-Mikesch, Cristina Bertinetti-Lapatki, Marcus Duehren-von Minden, Andrea Hafkemeyer, and Hendrik Veelken. "Idiotype Vaccination of Untreated Indolent B-Cell Lymphoma: Durable Objective Remissions and Association of Superior Outcome with Cellular Immune Responses." Blood 112, no. 11 (November 16, 2008): 235. http://dx.doi.org/10.1182/blood.v112.11.235.235.
Повний текст джерелаNeelapu, Sattva S., Nikhil C. Munshi, Sundar Jagannath, Thelma M. Watson, Robin Pennington, Bart Barlogie, and Larry W. Kwak. "Tumor Antigen Immunization of Sibling Stem Cell Transplant Donors in Multiple Myeloma." Blood 104, no. 11 (November 16, 2004): 3340. http://dx.doi.org/10.1182/blood.v104.11.3340.3340.
Повний текст джерелаSika-Paotonu, Dianne, and Urijah Liligeto. "The utility of Benzathine Penicillin G for Rheumatic Fever prevention in the Solomon Islands." Journal of Immunology 202, no. 1_Supplement (May 1, 2019): 229.1. http://dx.doi.org/10.4049/jimmunol.202.supp.229.1.
Повний текст джерелаTatochenko, V. K. "About immunoprevention vaccine schedule." PULMONOLOGIYA, no. 4 (August 28, 2007): 112–17. http://dx.doi.org/10.18093/0869-0189-2007-0-4-112-117.
Повний текст джерелаSchmitt, Heinz-J., Gudrun Maechler, Pirmin Habermehl, Markus Knuf, Roland Saenger, Norman Begg, and Dominique Boutriau. "Immunogenicity, Reactogenicity, and Immune Memory after Primary Vaccination with a Novel Haemophilus influenzae-Neisseria meningitidis Serogroup C Conjugate Vaccine." Clinical and Vaccine Immunology 14, no. 4 (February 7, 2007): 426–34. http://dx.doi.org/10.1128/cvi.00377-06.
Повний текст джерелаCohen, Adam D., Nikoletta Lendvai, Sacha Gnjatic, Achim A. Jungbluth, Stephane Bertolini, Linda Pan, Ralph Venhaus, et al. "Recombinant (rec) MAGE-A3 Protein Immunotherapy and Peripheral Blood Lymphocyte (PBL) Reconstitution Induce Strong Antigen-Specific Humoral and Cellular Immune Responses in Patients Undergoing Autologous Stem Cell Transplantation (ASCT) for Consolidation of Multiple Myeloma (MM)." Blood 124, no. 21 (December 6, 2014): 1184. http://dx.doi.org/10.1182/blood.v124.21.1184.1184.
Повний текст джерелаDoshi, Peter, Kyungwan Hong, Tom Jefferson, Mark Jones, and Anisa Rowhani-Farid. "Control vaccine formulation." Lancet 397, no. 10279 (March 2021): 1061–62. http://dx.doi.org/10.1016/s0140-6736(21)00382-2.
Повний текст джерелаBURGESS, M. A. "TWO DOSE MMR VACCINE SCHEDULE." Journal of Paediatrics and Child Health 30, no. 5 (October 1994): 453. http://dx.doi.org/10.1111/j.1440-1754.1994.tb00702.x.
Повний текст джерелаTUCKER, MIRIAM E. "Pneumococcal Vaccine Schedule Questions Persist." Family Practice News 38, no. 15 (August 2008): 21. http://dx.doi.org/10.1016/s0300-7073(08)70967-8.
Повний текст джерела&NA;. "Earlier response with accelerated vaccine schedule." Inpharma Weekly &NA;, no. 934 (April 1994): 16–17. http://dx.doi.org/10.2165/00128413-199409340-00031.
Повний текст джерела&NA;. "Reduced anthrax vaccine schedule remains effective." Inpharma Weekly &NA;, no. 1329 (March 2002): 19. http://dx.doi.org/10.2165/00128413-200213290-00041.
Повний текст джерелаPETER, GEORGES, and Henry C. Bodenheimer. "INTERRUPTION OF HEPATITIS B VACCINE SCHEDULE." Pediatric Infectious Disease Journal 4, no. 6 (November 1985): 707. http://dx.doi.org/10.1097/00006454-198511000-00041.
Повний текст джерелаMCNAMARA, DAMIAN. "Hasten Vaccine Schedule for International Travelers." Pediatric News 39, no. 3 (March 2005): 14. http://dx.doi.org/10.1016/s0031-398x(05)70021-7.
Повний текст джерелаWORCESTER, SHARON. "AAP Endorses New Rabies Vaccine Schedule." Pediatric News 45, no. 4 (April 2011): 4–5. http://dx.doi.org/10.1016/s0031-398x(11)70113-8.
Повний текст джерелаSaah, Alfred J., and Nubia Muñoz. "Control vaccine formulation – Authors' reply." Lancet 397, no. 10279 (March 2021): 1062. http://dx.doi.org/10.1016/s0140-6736(21)00437-2.
Повний текст джерела